Literature DB >> 1150561

Frequency and duration of interval training programs and changes in aerobic power.

E L Fox, R L Bartels, C E Billings, R O'Brien, R Bason, D K Mathews.   

Abstract

This study was designed to ascertain whether 7- and 13-wk interval training programs with training frequencies of 2 days/wk would produce improvement in maximal aerobic power (VO2max) comparable to that obtained from 7- and 13-wk programs of the same intensity consisting of 4 training days/wk. Sixty-nine young healthy college males were used as subjects. After training, there was a significant increase in VO2max (bicycle ergometer, open-circuit spirometry) that was independent of both training frequency and duration. However, there was a trend for greater gains after 13 wk. Maximal heart rate (direct lead ECG) was significantly decreased following training, being independent of both training frequency and duration. Submaximal VO2 did not change with training but submaximal heart rate decreased significantly with greater decreases the more frequent and longer the training. Within the limitations of this study, these results indicate that: 1) maximal stroke volume and/or maximal avO2 difference, principle determinants of VO2max, are not dependent on training frequency nor training duration, and 2) one benefit of more frequent and longer duration interval training is less circulatory stress as evidenced by decreased heart rate, during submaximal exercise.

Entities:  

Mesh:

Year:  1975        PMID: 1150561     DOI: 10.1152/jappl.1975.38.3.481

Source DB:  PubMed          Journal:  J Appl Physiol        ISSN: 0021-8987            Impact factor:   3.531


  20 in total

Review 1.  A proposed model for examining the interference phenomenon between concurrent aerobic and strength training.

Authors:  D Docherty; B Sporer
Journal:  Sports Med       Date:  2000-12       Impact factor: 11.136

Review 2.  Interval training for performance: a scientific and empirical practice. Special recommendations for middle- and long-distance running. Part II: anaerobic interval training.

Authors:  L V Billat
Journal:  Sports Med       Date:  2001-02       Impact factor: 11.136

Review 3.  Interval training for performance: a scientific and empirical practice. Special recommendations for middle- and long-distance running. Part I: aerobic interval training.

Authors:  L V Billat
Journal:  Sports Med       Date:  2001       Impact factor: 11.136

4.  Short- and long-term effects of a single bout of exercise on heart rate variability: comparison between constant and interval training exercises.

Authors:  Laurent Mourot; Malika Bouhaddi; Nicolas Tordi; Jean-Denis Rouillon; Jacques Regnard
Journal:  Eur J Appl Physiol       Date:  2004-08       Impact factor: 3.078

5.  Vascular adaptations to hypobaric hypoxic training in postmenopausal women.

Authors:  Masato Nishiwaki; Ryoko Kawakami; Kazuto Saito; Hiroyuki Tamaki; Hiroaki Takekura; Futoshi Ogita
Journal:  J Physiol Sci       Date:  2010-12-22       Impact factor: 2.781

Review 6.  Aerobic conditioning for team sport athletes.

Authors:  Nicholas M Stone; Andrew E Kilding
Journal:  Sports Med       Date:  2009       Impact factor: 11.136

7.  Intermittent versus constant aerobic exercise: effects on arterial stiffness.

Authors:  Nicolas Tordi; Laurent Mourot; Eglantine Colin; Jacques Regnard
Journal:  Eur J Appl Physiol       Date:  2010-03       Impact factor: 3.078

8.  Effects of combined exercise on gait variability in community-dwelling older adults.

Authors:  Ray-Yau Wang; Yuan-Li Wang; Fang-Yu Cheng; Yuan-Hung Chao; Chien-Liang Chen; Yea-Ru Yang
Journal:  Age (Dordr)       Date:  2015-04-25

Review 9.  Tabata training: one of the most energetically effective high-intensity intermittent training methods.

Authors:  Izumi Tabata
Journal:  J Physiol Sci       Date:  2019-04-19       Impact factor: 2.781

Review 10.  Physiological adaptations to interval training and the role of exercise intensity.

Authors:  Martin J MacInnis; Martin J Gibala
Journal:  J Physiol       Date:  2016-12-07       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.